Loading…
Reported covered position: Covered Official Positions Continued: Health Policy Advisor, Congresswoman Cathy McMorris Rogers; Staff Assistant / Legislative Correspondent / Legislative Assistant, Congressman Ryan Costello
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NOVOCURE INC. via NOVOCURE INC.
2026 · third_quarter · Q3
Tariff issues, specifically related to medical device 232.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
Source: Senate LDA
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: NOVOCURE INC. · Firm: NOVOCURE INC.
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
2026 · second_quarter · Q2
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Tariff issues, specifically related to medical device 232.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
NOVOCURE INC. via NOVOCURE INC.
2026 · first_quarter · Q1
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Tariff issues, specifically related to medical device 232.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2025 · fourth_quarter · Q4
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Tariff issues, specifically related to medical device 232.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2025 · third_quarter · Q3
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2025 · second_quarter · Q2
General Medicare Issues. S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Veterans Affairs / Veterans Health Administration (VHA) issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2025 · first_quarter · Q1
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
Veterans Affairs / Veterans Health Administration (VHA) issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2024 · fourth_quarter · Q4
General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.
Veterans Affairs / Veterans Health Administration (VHA) issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVOCURE INC. via NOVOCURE INC.
2024 · third_quarter · Q3
Veterans Affairs / Veterans Health Administration (VHA) issues.
General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE